1035 related articles for article (PubMed ID: 18574772)
21. [Experimental study on IL-2- and IL-15 application in allogeneic hematopoietic stem cell transplantation].
Chen GH; Wu DP; Sun AN; Yang MZ; Wang Y; Tang XW; Chang HR; Feng YF; Zhu ZL
Zhonghua Xue Ye Xue Za Zhi; 2008 Aug; 29(8):526-30. PubMed ID: 19112915
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of cytotoxic function and apoptosis in interleukin (IL)-12/IL-15-treated umbilical cord or adult peripheral blood natural killer cells by a propidium-iodide based flow cytometry.
Lin SJ; Cheng PJ; Huang YJ; Kuo ML
Pediatr Allergy Immunol; 2004 Feb; 15(1):79-85. PubMed ID: 14998386
[TBL] [Abstract][Full Text] [Related]
23. Intracellular cytokine profile of cord blood T-, and NK- cells and monocytes.
Krampera M; Tavecchia L; Benedetti F; Nadali G; Pizzolo G
Haematologica; 2000 Jul; 85(7):675-9. PubMed ID: 10897117
[TBL] [Abstract][Full Text] [Related]
24. Effect of IL-21 on NK cells derived from different umbilical cord blood populations.
Perez SA; Mahaira LG; Sotiropoulou PA; Gritzapis AD; Iliopoulou EG; Niarchos DK; Cacoullos NT; Kavalakis YG; Antsaklis AI; Sotiriadou NN; Baxevanis CN; Papamichail M
Int Immunol; 2006 Jan; 18(1):49-58. PubMed ID: 16291655
[TBL] [Abstract][Full Text] [Related]
25. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
[TBL] [Abstract][Full Text] [Related]
26. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells.
Nguyen QH; Roberts RL; Ank BJ; Lin SJ; Thomas EK; Stiehm ER
Cell Immunol; 1998 May; 185(2):83-92. PubMed ID: 9636686
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic and functional heterogeneity of natural killer cells from umbilical cord blood mononuclear cells.
Fan YY; Yang BY; Wu CY
Immunol Invest; 2008; 37(1):79-96. PubMed ID: 18214801
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of mycophenolate mofetil and cyclosporine A on peripheral blood and cord blood natural killer cells activated with interleukin-2.
Derniame S; Perazzo J; Lee F; Domogala A; Escobedo-Cousin M; Alnabhan R; Luevano M; Pedroza-Pacheco I; Cooper N; Madrigal A; Saudemont A
Cytotherapy; 2014 Oct; 16(10):1409-18. PubMed ID: 24969967
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility to Fas and tumor necrosis factor-alpha receptor mediated apoptosis of anti-CD3/anti-CD28-activated umbilical cord blood T cells.
Lin SJ; Lee CC; Cheng PJ; See LC; Kuo ML
Pediatr Allergy Immunol; 2009 Jun; 20(4):392-8. PubMed ID: 18713315
[TBL] [Abstract][Full Text] [Related]
31. Differential effect of IL-15 and IL-2 on survival of phytohemagglutinin-activated umbilical cord blood T cells.
Lin SJ; Cheng PJ; Hsiao SS; Lin HH; Hung PF; Kuo ML
Am J Hematol; 2005 Oct; 80(2):106-12. PubMed ID: 16184573
[TBL] [Abstract][Full Text] [Related]
32. The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation.
Luevano M; Daryouzeh M; Alnabhan R; Querol S; Khakoo S; Madrigal A; Saudemont A
Hum Immunol; 2012 Mar; 73(3):248-57. PubMed ID: 22234167
[TBL] [Abstract][Full Text] [Related]
33. A Wilms tumor cell line, HFWT, can greatly stimulate proliferation of CD56+ human natural killer cells and their novel precursors in blood mononuclear cells.
Harada H; Watanabe S; Saijo K; Ishiwata I; Ohno T
Exp Hematol; 2004 Jul; 32(7):614-21. PubMed ID: 15246157
[TBL] [Abstract][Full Text] [Related]
34. Ex vivo expansion of natural killer cells for clinical applications.
Klingemann HG; Martinson J
Cytotherapy; 2004; 6(1):15-22. PubMed ID: 14985163
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
36. Bcl-xL is associated with the anti-apoptotic effect of IL-15 on the survival of CD56(dim) natural killer cells.
Zheng X; Wang Y; Wei H; Ling B; Sun R; Tian Z
Mol Immunol; 2008 May; 45(9):2559-69. PubMed ID: 18295891
[TBL] [Abstract][Full Text] [Related]
37. Enhanced in vitro and in vivo cytotoxicity of umbilical cord blood cells against human breast cancer following activation with IL-15 and colony stimulating factors.
Lovgren TR; Tarantolo SR; Evans C; Kuszynski CA; Joshi SS
In Vivo; 2002; 16(6):541-50. PubMed ID: 12494899
[TBL] [Abstract][Full Text] [Related]
38. Antitumor therapeutic potential of activated human umbilical cord blood cells against leukemia and breast cancer.
Joshi SS; Tarantolo SR; Kuszynski CA; Kessinger A
Clin Cancer Res; 2000 Nov; 6(11):4351-8. PubMed ID: 11106253
[TBL] [Abstract][Full Text] [Related]
39. High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity.
Wang Y; Xu H; Zheng X; Wei H; Sun R; Tian Z
Cell Mol Immunol; 2007 Oct; 4(5):377-82. PubMed ID: 17976318
[TBL] [Abstract][Full Text] [Related]
40. Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression.
Decot V; Voillard L; Latger-Cannard V; Aissi-Rothé L; Perrier P; Stoltz JF; Bensoussan D
Exp Hematol; 2010 May; 38(5):351-62. PubMed ID: 20172016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
